Staar Surgical (STAA)

Company Profile

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or 'ICL', which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland.

Company profile

Ticker

STAA

Exchange

NASDAQ

Website

www.staar.com

CEO

Caren Mason

Incorporated

Delaware

Location

California

Fiscal year end

Dec 30

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Ophthalmic Goods

Bausch + Lomb • Alcon Inc. - Registered Shares • National Vision • Warby Parker • RxSight • Cooper Companies • Innovative Eyewear • Luxottica Group Spa ...

Former names

STAAR SURGICAL COMPANY

SEC CIK

0000718937

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

STAAR Surgical UK LTD • STAAR Surgical AG • STAAR Japan Inc. • STAAR Surgical PTE. LTD • Technology (Shanghai) Co., LTD • CO., LTD • STAAR Surgical India Private Limited ...

IRS number

953797439

STAA stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$77.17

Low target

$60.00

High target

$85.00

BTIG

Maintains

Buy

$80.00

3 Nov 22

Needham

Maintains

Buy

$83.00

3 Nov 22

Latest filings (excl ownership)

View all

8-K

Amendments to Articles of Incorporation or Bylaws

1 Feb 23

8-K

STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022

9 Jan 23

8-K

STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO

19 Dec 22

8-K

STAA.OQ - Q3 2022 STAAR Surgical Co Earnings Call

2 Nov 22

STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

2 Nov 22

8-K

Regulation FD Disclosure

10 Aug 22

STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y

10 Aug 22

8-K

Departure of Directors or Certain Officers

20 Jul 22

Transcripts

View all

STAA

Earnings call transcript

2022 Q2

11 Aug 22

STAA

Earnings call transcript

2022 Q1

4 May 22

STAA

Earnings call transcript

2021 Q4

24 Feb 22

STAA

Earnings call transcript

2021 Q3

4 Nov 21

STAA

Earnings call transcript

2021 Q2

5 Aug 21

STAA

Earnings call transcript

2021 Q1

6 May 21

STAA

Earnings call transcript

2020 Q4

25 Feb 21

STAA

Earnings call transcript

2020 Q3

4 Nov 20

STAA

Earnings call transcript

2020 Q3

4 Nov 20

STAA

Earnings call transcript

2020 Q2

5 Aug 20

Latest ownership filings

View all

Financial summary

Financial statements Chart STAA financial data

Quarter (USD)	Sep 22	Jul 22	Apr 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Jan 21	Jan 20	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	129.24 mm	129.24 mm	129.24 mm	129.24 mm	129.24 mm	129.24 mm
Cash burn (monthly)	24.42 mm	5.58 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	100.81 mm	23.05 mm	n/a	n/a	n/a	n/a
Cash remaining	28.43 mm	106.19 mm	n/a	n/a	n/a	n/a
Runway (months of cash)	1.2	19.0	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2022

STAA institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	293	265	+10.6%
Opened positions	53	32	+65.6%
Closed positions	25	33	-24.2%
Increased positions	104	118	-11.9%
Reduced positions	99	76	+30.3%

13F shares	Current	Prev Q	Change
Total value	7.82 bn	3.27 bn	+139.3%
Total shares	54.07 mm	54.68 mm	-1.1%
Total puts	415.40 k	194.80 k	+113.2%
Total calls	928.30 k	486.20 k	+90.9%
Total put/call ratio	0.4	0.4	+11.7%

Largest owners	Shares	Value	Change
Broadwood Partners	8.59 mm	$0.00	0.0%
Broadwood Capital	8.59 mm	$606.17 mm	0.0%
BLK Blackrock	5.60 mm	$394.83 mm	-1.6%
Vanguard	5.22 mm	$368.16 mm	+1.1%
Baillie Gifford & Co	5.13 mm	$361.77 mm	-3.0%
Palo Alto Investors	1.10 mm	$77.39 mm	-0.9%
Geneva Capital Management	947.13 k	$66.82 mm	+4.2%
Geode Capital Management	870.93 k	$61.44 mm	+2.3%
E Fund Management	732.30 k	$51.66 mm	0.0%
PFG Principal Financial Group Inc - Registered Shares	693.12 k	$48.90 mm	+26.4%

Largest transactions	Shares	Bought/sold	Change
STT State Street	0.00	-1.56 mm	EXIT
MS Morgan Stanley	609.27 k	+320.95 k	+111.3%
Nicholas Investment Partners	166.32 k	+166.32 k	NEW
Baillie Gifford & Co	5.13 mm	-157.56 k	-3.0%
PFG Principal Financial Group Inc - Registered Shares	693.12 k	+144.92 k	+26.4%
Cinctive Capital Management	0.00	-138.48 k	EXIT
Millennium Management	182.80 k	+128.41 k	+236.1%
Bessemer	163.63 k	+112.01 k	+217.0%
Lisanti Capital Growth	68.16 k	-101.85 k	-59.9%
MNGPF Man	95.33 k	+95.33 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

STAA insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Jan 23	Frinzi Thomas G	Common Shares	Option exercise	Acquire M	No	No	0	87,805	0.00	92,534
3 Jan 23	Frinzi Thomas G	Common Stock Options Common Stock	Option exercise	Acquire M	No	No	51.25	160,638	8.23 mm	160,638
30 Dec 22	James E Francese	Common Stock Options Common Stock	Option exercise	Acquire M	No	No	48.54	19,139	929.01 k	19,139
29 Dec 22	Broadwood Partners	Common Stock	Buy	Acquire P	Yes	No	0	0	0.00	8,783,082
29 Dec 22	Broadwood Partners	Common Stock	Buy	Acquire P	No	No	47.9261	39,090	1.87 mm	8,783,082
28 Dec 22	Broadwood Partners	Common Stock	Buy	Acquire P	Yes	No	0	0	0.00	8,743,992
28 Dec 22	Broadwood Partners	Common Stock	Buy	Acquire P	No	No	46.9761	100,000	4.70 mm	8,743,992
27 Dec 22	Broadwood Partners	Common Stock	Buy	Acquire P	Yes	No	0	0	0.00	8,643,992
27 Dec 22	Broadwood Partners	Common Stock	Buy	Acquire P	No	No	47.9087	51,985	2.49 mm	8,643,992
27 Sep 22	James E Francese	Common Stock	Sell	Dispose S	No	No	75	13,075	980.63 k	34,908